clarithromycin has been researched along with Peptic Ulcer in 334 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 103 (30.84) | 18.2507 |
2000's | 168 (50.30) | 29.6817 |
2010's | 53 (15.87) | 24.3611 |
2020's | 10 (2.99) | 2.80 |
Authors | Studies |
---|---|
Alcedo, J; Amador, J; Bujanda, L; Calvet, X; Castro-Fernández, M; Fernández-Salazar, L; Gené, E; Gisbert, JP; Lanas, Á; Lucendo, AJ; Molina-Infante, J; Nyssen, OP; Pérez-Aisa, A; Puig, I | 1 |
Chen, YC; Li, YD; Yu, BH | 1 |
Bai, G; Du, H; Yi, J; Yu, Y | 1 |
Avery, A; Coupland, CAC; Crooks, C; Dumbleton, J; Hawkey, C; Hobbs, FDR; Kendrick, D; Moore, M; Morris, C; Rubin, G; Smith, M; Stevenson, D | 1 |
Hoang, VT; Tran, TNQ; Tran, TQA; Vu, DL; Vu, TB | 1 |
Couturier, MR; Shakir, FA; Shakir, SM | 1 |
Cogdill, AG; Guevara, B | 1 |
Alshareef, A; Bach Dat, B; Duc, NT; Nam, NH; Ngoc, NM; Nguyen, JG; Reda, A; Thieu, H; Tien Huy, N | 1 |
Pan, L; Tang, G; Tang, Y; Wei, Z; Zhou, S; Zhu, H | 1 |
Bang, MTL; Duc, NM; Khoi, HH; Nghi, BTD; Ngoc, TLC; Tien, VNT; Van Bach, N; Van Thieu, H | 1 |
Andreev, DN; Dicheva, DT; Maev, IV; Partzvania-Vinogradova, EV; Samsonov, AA | 1 |
Andreev, DN; Dicheva, DT; Maiev, IV; Partzvania-Vinogradova, EV; Yurenev, GL | 1 |
Abbas, Z; Abid, S; Ahmed, R; Hamid, S; Jafri, W; Mumtaz, K; Yakoob, J | 1 |
Malfertheiner, P | 1 |
Almasi, S; Mirsattari, D; Seyedmajidi, S; Seyyedmajidi, M; Zali, M; Zanganeh, E; Zojaji, H | 1 |
Botero, ML; Cárdenas, A; Forero, JD; Rey, M; Sierra, F | 1 |
Barrio, J; Bory, F; Calvet, X; Castro, M; de la Coba, C; Ducons, J; Forné, M; Gisbert, JP; Marin, AC; McNicholl, AG; Molina-Infante, J; Montoro, M; Perez-Aisa, A | 1 |
Chen, A; Chen, JJ; Hsu, PI; Hsu, WH; Kuo, CH; Kuo, FC; Liu, CJ; Liu, MK; Lu, CY; Su, YC; Wu, DC; Wu, IC; Yu, FJ | 1 |
Benzer, E; Bilir, G; Gokcan, H; Onal, IK; Oztas, E | 1 |
Abbas, Z; Awan, S; Hamid, S; Jafri, F; Jafri, W; Naz, S; Usman, MW; Yakoob, J | 1 |
Jang, JY; Jung, HK; Kim, CG; Kim, SG; Lee, H; Lee, HL; Lee, YC; Shin, ES; Shin, WG | 1 |
Bosques-Padilla, FJ; Garza-González, E; Maldonado-Garza, HJ; Perez-Perez, GI | 1 |
Brandimarte, G; Elisei, W; Giorgetti, G; Picchio, M; Tursi, A | 1 |
Chen, BP; Chen, YH; Huang, GR; Huang, XF; Huang, YQ; Huang, ZS; Li, XH; Mo, XQ; Qin, YC; Tang, HY; Wang, LY; Wei, HY; Wei, LD; Zhao, LJ | 1 |
Arj, A; Dastehgoli, K; Keshavarz Azizi Raftar, S; Mirzaei Ghazi Kalayeh, H; Moniri, R; Mousavi, SG; Razavi Zadeh, M; Saffari, M | 1 |
Tu, S; Yang, H | 1 |
Fischbach, W; Glocker, E; Malfertheiner, P; Scherübl, H | 1 |
Bari, Z; Fakheri, H; Hosseini, V; Maleki, I; Metanat, HA; Taghvaei, T; Valizadeh, SM | 1 |
Andrianov, M; Azzam, R; Rivera, E | 1 |
Bai, P; Ding, Y; Luo, Y; Xiao, XM; Zhou, LY | 1 |
Chun, J; Kim, BG; Kim, BS; Kim, JS; Kim, JW; Koh, SJ; Lee, KL; Oh, B | 1 |
Alimadadi, M; Amirkhanlou, S; Hafezi, AA; Homapour, S; Seyyedmajidi, M; Vafaeimanesh, J; Vakili, MA | 1 |
Bhatt, NR; Bhatt, R; Kakked, GA | 1 |
Forte, A; Jeverica, S; Šeruga, M; Stefanovič, M; Tepeš, B; Vujasinović, M | 1 |
Asaka, M; Funao, N; Murakami, K; Nishimura, A; Sakurai, Y; Shiino, M | 1 |
Georgopoulos, SD; Grivas, E; Kasapidis, P; Laoudi, F; Martinez-Gonzales, B; Mentis, A; Michopoulos, S; Petraki, K; Sgouras, D; Sotiropoulou, M; Spiliadi, C; Xirouchakis, E; Zampeli, E; Zografos, K | 1 |
Oberhofer, E | 1 |
Boudebesse, C; Etain, B; Henry, C; Legendre, T | 1 |
Katelaris, P; Mitchell, H | 1 |
Hsu, TH; Huang, KW; Lin, LC; Tam, KW | 1 |
Biglarian, O; Ghamarchehreh, ME; Khonche, A; Majeed, M; Panahi, Y; Sahebkar, A; Soflaei, SS; Valizadegan, G | 1 |
Fujita, M; Graham, DY; Haruma, K; Ishii, M; Kamada, T; Katsumata, R; Matsumoto, H; Murao, T; Nakato, R; Shiotani, A | 1 |
Inoue, H; Ito, M; Kasai, C; Moritani, I; Oya, Y; Shiraki, K; Sugimoto, K; Takase, K; Takei, Y; Tameda, M; Tanaka, J | 1 |
Cho, YK; Choi, WH; Hong, CH; Hong, EJ; Jeon, WK; Kim, BI; Kim, HJ; Oh, SJ; Park, DI; Park, JH; Shon, CI; Song, MJ | 1 |
Cristofari, F; Hassan, C; Zullo, A | 1 |
Oganesian, TS | 1 |
Arigbabu, AO; Coker, AO; Oyedeji, KS; Smith, SI | 1 |
Buka, GIu; Veligotskiĭ, NN | 1 |
Fukase, K; Kawata, S; Mabe, K; Matsuda, T; Oizumi, H; Shibata, A; Takahashi, M; Takeda, H; Tsukuma, H | 1 |
Dixit, VK; Gulati, AK; Jain, AK; Maurya, P; Mishra, S; Nath, G; Rao, G; Singh, V | 1 |
Choe, YH; Chung, IS; Kim, HS; Kim, JI; Kim, JJ; Kim, N | 1 |
Kucheriavyĭ, IuA | 1 |
Dorshimer, GW; Kim, PK | 1 |
Lay, CS; Lin, CJ; Lin, JR | 1 |
Ayadi, A; Ben Mansour, K; Boubaker, J; Burucoa, C; Cheikh, I; Chouaib, S; Fekih, M; Fendri, C; Filali, A; Hriz, MB; Kallel, L; Karoui, S; Labbene, M; Maherzi, A; Mami, NB; Masmoudi, A; Matri, S; Najjar, T; Sfar, MT; Siala, N; Zarrouk, S; Zribi, M | 1 |
Agah, S; Ebrahimi-Dariani, N; Khatibian, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Pourshams, A; Riahizadeh, S; Sotoudehmanesh, R; Vahedi, H; Zendehdel, N | 1 |
Buzás, GM | 2 |
Boyanova, L; Cabrita, AM; de Carvalho, JN; Gonçalves, TM; Medeiros, JA; Pereira, AM; Pereira, MI | 1 |
Barbuti, RC; Eisig, JN; Felga, G; Navarro-Rodriguez, T; Silva, FM; Zaterka, S | 1 |
Bytzer, P; Dahlerup, JF; Eriksen, JR; Jarbøl, DE; Rosenstock, S; Wildt, S | 1 |
Cadranel, S; Casswall, T; Chong, S; Colletti, RB; Elitsur, Y; Gold, B; Goodman, KJ; Guarner, J; Jones, NL; Kalach, N; Koletzko, S; Madrazo, A; Megraud, F; Oderda, G; Rowland, M | 1 |
Choi, KH; Chung, WC; Jung, SH; Kang, BK; Kim, EJ; Lee, KM; Oak, JH; Paik, CN | 1 |
Jung, SW; Kim, SY | 1 |
Hwang, JH; Jeong, SH; Jo, HJ; Jung, HC; Kim, JM; Kim, JW; Kim, JY; Kim, N; Lee, DH; Lee, JH; Lee, SH; Nam, RH; Park, HK; Park, YS; Shin, CM; Song, IS | 1 |
Calvet, X; Gisbert, JP | 1 |
Cho, KB; Jeon, SW; Jung, JT; Jung, MK; Kim, ES; Kim, EY; Kim, KO; Kwon, JG; Lee, JH; Lee, SH; Park, HG; Park, KS; Seo, HE; Yang, CH | 1 |
Fragou, P; Georgopoulos, S; Karatapanis, S; Laudi, F; Lisgos, P; Papantoniou, N; Papastergiou, V; Skorda, L; Spiliadi, C; Xirouchakis, E | 1 |
Belousova, NL; Firsova, LD; Goncharenko, LS; Govorun, VM; Ianova, OB; Kashnikov, VS; Kim, VA; Masharova, AA; Shcherbakov, PL; Shcherbakova, MIu | 1 |
Chen, TH; Chiang, H; Chiu, HM; Lee, YC; Lin, JT; Liu, TY; Shun, CT; Wu, MS | 1 |
Fakheri, H; Hosseini, V; Maleki, I; Mokhtare, M; Sardarian, H; Taghvaei, T | 1 |
Ang, D; Ang, TL; Chiam, P; Fock, KM; Teo, EK; Wang, L | 1 |
Hibi, T; Nishizawa, T; Suzuki, H; Tsugawa, H | 1 |
Inaba, T; Kawai, K; Miyoshi, M; Mizuno, M; Oguma, K; Okada, H; Take, S; Tsuji, T; Yokota, K | 1 |
Andreu, V; Bory, F; Calvet, X; Ducons, J; Guardiola, J; Guirao, R; Tito, L | 1 |
Blum, AL; Bolten, WW; Dragosics, B; Koelz, HR; Labenz, J; Rösch, W; Stolte, M | 1 |
Chiba, T; Watanabe, T | 2 |
Iwabuchi, H; Matsuzaki, K | 1 |
Lam, EK; Lo, KY; Loo, CK; Mak, SK; Tong, GM; Wong, AK; Wong, AM; Wong, PN | 1 |
Ando, T; Ina, K; Kawamura-Sato, K; Kusugami, K; Nobata, K; Ohta, M; Tsuzuki, T | 1 |
De Francesco, V; Faleo, D; Ierardi, E; Margiotta, M; Panella, C | 1 |
Handa, Y; Kawai, T; Kawakami, K; Kudo, T; Moriyasu, F; Ogiahara, S | 1 |
Go, MF | 1 |
Chung, IS; Chung, KW; Kim, JI; Kim, JK; Park, SH; Sun, HS | 1 |
Kullavanijaya, P; Tangkijvanich, P; Thong-Ngam, D; Treeprasertsuk, S; Wisedopas, N | 1 |
Schuster, MJ | 1 |
Habu, Y; Hayakumo, T; Inokuchi, H; Kawabata, H; Kawai, K; Kimoto, K; Kiyota, K; Kobayashi, M; Kutsumi, H; Mizuno, S; Nakajima, M; Oyasu, K; Tomioka, H | 1 |
Aoyama, N; Kasuga, M; Kita, T; Kuroda, K; Maekawa, S; Miki, I; Okumura, K; Sakaeda, T; Sakai, T; Shirasaka, D; Tamura, T; Wambura, CM | 1 |
Alarcón, T; Baquero, M; García-Samaniego, J; Toro, C | 1 |
Atherton, JC; Hawkey, CJ; Ravic, M; Thjodleifsson, B; Treichel, HC | 1 |
Asaka, M | 1 |
Asaka, M; Fujioka, T; Fukuda, Y; Kato, M; Kimura, K; Kobayashi, S; Kuwayama, H; Satoh, K; Shimizu, K; Shimoyama, T; Sugiyama, T; Takemoto, T | 2 |
Chehter, EZ; Eisig, JN; Hashimoto, C; Laudanna, AA; Silva, FM | 1 |
Bermejo, F; Boixeda, D; García Plaza, A; Hernández Ranz, F; López Sanromán, A; Martín De Argila, C | 1 |
Eun, CS; Hahm, JS; Han, DS; Jeon, YC; Kang, JO; Kim, KS; Park, JY | 1 |
Ekström, P; Hellblom, M; Kihira, K; Kimura, K; Ohlin, B; Satoh, K; Sipponen, P; Stubberöd, A; Unge, P; Yoshida, Y; Yube, T | 1 |
Biagi, GL; Cantelli-Forti, G; Gatta, L; Miglioli, M; Paolini, M; Perna, F; Ricci, C; Sapone, A; Tampieri, A; Trespidi, S; Vaira, D | 1 |
Björkman, A; Granström, M; Hoang, TT; Phung, DC; Sörberg, M; Wheeldon, TU | 1 |
Laine, L | 1 |
Lam, EK; Lo, KY; Loo, CK; Mak, SK; Tong, GM; Wong, AK; Wong, PN | 1 |
Hoshino, Y; Ishii, H; Kurabayashi, K; Masaoka, T; Minegishi, Y; Nomura, S; Suzuki, H; Suzuki, M | 1 |
Choi, BK; Chung, JM; Jang, YS; Lee, SH; Lee, YJ; Park, ET; Seol, SY; Yang, SY | 1 |
Chan, CK; Chan, OO; Chu, KM; Hu, HC; Hui, WM; Kwok, KF; Lai, KC; Lam, SK; Wong, BC; Wong, WM | 1 |
Carpenter, CF; Neuhann, HF; Shao, O; Swai, B | 1 |
Bochenek, WJ; Davis, KD; El-Zimaity, HM; Fraga, PD; Graham, DY; Mack, ME; Osato, MS; Peters, S; Wang, W | 1 |
Bilardi, C; Dulbecco, P; Gambaro, C; Iiritano, E; Mansia, C; Savarino, V; Usai, P; Vigneri, S; Zentilin, P | 1 |
Ayyagari, A; Bhasin, D; Das, BK; Dharmalingam, S; Habibullah, CM; Khan, AA; Naik, SR; Rajasambandam, P; Ramathilagam, B; Rao, UA; Ray, P; Sharma, MP; Thyagarajan, SP | 1 |
Berlanga, C; Gutiérrez-Mora, D; Ortíz-Domínguez, A | 1 |
Uzun, C | 1 |
Barone, M; Berloco, P; Burattini, O; De Francesco, V; Di Leo, A; Francavilla, A; Ierardi, E; Marangi, S; Margiotta, M; Minenna, MF; Morini, S; Panella, C; Russo, F; Stoppino, V; Zullo, A | 1 |
Saltanova, SD; Tkach, OS | 1 |
Chen, JH; Chen, TJ; Lee, SC; Wang, GM; Yang, KC | 1 |
El-Omar, EM; Furuta, T; Ishizaki, T; Ohashi, K; Rabkin, CS; Shirai, N; Sugimura, H; Xiao, F | 1 |
Hotz Dagger, J; Leodolter, A; Malfertheiner, P; Peitz, U; Plein, K; Raps, S | 1 |
Fujioka, T; Kobayashi, I; Muraoka, H; Nasu, M; Nishida, M; Saika, T | 1 |
Furuta, Y; Miyasaka, K; Sugiyama, T; Yoshioka, M | 1 |
Ahuja, V; Bal, C; Bhatia, V; Das, B; Sharma, MP | 1 |
De Francesco, V; Della Valle, N; Hassan, C; Ierardi, E; Minenna, MF; Monno, R; Morini, S; Panella, C; Pietrini, L; Stoppino, V; Winn, S; Zullo, A | 1 |
Granström, M; Hoang, TT; Nilsson, LE; Phuncarg, DC; Sörberg, M; Wheeldon, TU | 1 |
Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kondo, Y; Nomura, T; Ohara, H; Oshima, T; Sasaki, M; Tanida, S | 1 |
Fukuda, Y; Sakagami, T | 1 |
Isakov, VA | 1 |
Arakawa, Y; Kanai, K; Shibayama, K; Suzuki, S; Wachino, J | 1 |
Schuster, M | 1 |
Arslan, H; Boyacioğlu, S; Can, F; Demirbilek, M; Selçuk, H | 1 |
Feng, LY; Jiang, SL; Yao, XX | 1 |
Chey, WD; Saad, R | 1 |
Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Ohnita, K; Wen, CY | 1 |
Jeong, BC; Kang, GH; Lee, HK; Lee, JH; Lee, SH; Roe, IH; Shin, JH; Sohn, SG | 1 |
Terano, A | 1 |
Cao, DZ; Fu, XL; Hu, JM; Ou, XL; Su, H; Sun, WH; Sun, YL; Yu, Q; Yu, T; Zhu, F | 1 |
Cho, YK; Jeon, WK; Keum, DK; Kim, BI; Kim, HJ; Kim, SH; Park, DI; Park, SH; Sohn, CI; Sung, IK | 1 |
Dobrenko, VA; Grinevich, VB; Gubonina, IV; Sablin, OA | 1 |
Bernabucci, V; Cavina, M; De Francesco, V; Gatta, L; Hassan, C; Ierardi, E; Morini, S; Ricci, C; Vaira, D; Zullo, A | 1 |
Almeida, JR; Campos, LT; Guerrazzi, F; Lorena, SL; Mesquita, MA; Montes, CG; Zeitune, JM | 1 |
Bory, F; Bujanda, L; Calvet, X; Ducons, J; Gisbert, JP; Montserrat, A | 1 |
Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kondo, Y; Nakao, H; Ogasawara, N; Ohara, H; Okada, N; Oshima, T; Sano, H; Sasaki, M; Sobue, S; Tanida, S | 1 |
Chen, X; Jia, Y; Liu, SJ; Shen, SR; Tang, WL; Wang, F; Wang, XY; Xu, CX | 1 |
Ando, T; El-Omar, E; Goto, H; Ina, K; Ishiguro, K; Kusugami, K; Minami, M; Mizuno, T; Nishiwaki, T; Nobata, K; Shimada, M; Tsuzuki, T; Watanabe, O | 1 |
Carvalhaes, A; Magalhães, AF; Natan-Eisig, J; Paraíso-Ferraz, JG; Trevisan, M; Zaterkaad, S | 1 |
Chen, FB; Chen, J; Chen, XJ; Li, ZY; Yu, JD; Zhang, XP | 1 |
Chen, JL; Chen, WC; Cheng, JS; Hsu, PI; Lai, KH; Lin, CK; Lo, CC; Lo, GH; Tsay, FW; Tseng, HH; Wu, CJ; Yamaoka, Y; Yu, HC | 1 |
Vakil, N | 1 |
Bertin, P; Broutet, N; Combe, B; Joubert-Collin, M; Lamouliatte, H; Mégraud, F; Perié, F; Schaeverbeke, T; Zerbib, F | 1 |
Amoruso, A; Burattini, O; Cea, U; de Francesco, V; Hassan, C; Ierardi, E; Margiotta, M; Morini, S; Panella, C; Stella, F; Stoppino, G; Valle, ND; Zullo, A | 1 |
Donovan, JL; Egger, M; Harvey, IM; Harvey, RF; Lane, JA; Murray, LJ; Nair, P; Noble, S | 1 |
Deguchi, R; Kobayashi, I; Kobayashi, K; Kurumada, T; Masui, A; Matsushima, M; Mine, T; Muraoka, H; Shirai, T; Suzuki, T; Takagi, A; Watanabe, K; Watanabe, S | 1 |
Abe, T; Arita, T; Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S; Watanabe, K | 1 |
Butorov, IV; Butorov, SI; Maksimov, VV; Osoianu, IuP | 2 |
Ashorn, M; Bodanszky, H; Bontems, P; Casswall, T; Celinska-Cedro, D; Crone, J; Gottrand, F; Kalach, N; Kolacek, S; Koletzko, S; Martínez-Gómez, MJ; Mégraud, F; Monteiro, ML; Orderda, G; Richy, F; Roma-Giannikou, E; Urruzuno, P | 1 |
Lule, GN | 1 |
Chan, FK; Ching, JY; Lau, W; Lee, IY; Lee, KK; You, JH; Yung, M | 1 |
Díte, P; Dostalík, Z; Hegyi, P; Hůlek, P; Králová, Z; Kunovská, M; Kyzeková, J; Matejovic, F; Novotný, I; Pásková, J; Petrtýl, J; Procházka, V; Pulgretová, D; Samek, M; Vyhnálek, P; Weinberg, J; Woznica, V; Zelenková, J | 1 |
Ferrara, EC; Manes, G; Porro, GB | 1 |
Takahashi, S; Tanaka, A; Tokunaga, K | 1 |
Bosboom, R; de Boer, SY; de Boer, WA; Hendrikse, L; Jansen, JB; Janssen, MJ; Laheij, RJ | 1 |
Lee, KH; Tam, YH; Yeung, CK | 1 |
Dzieniszewski, J; Jarosz, M | 1 |
Stege, PW; Vega, AE | 1 |
Bucki, R; Gotebiewska, M; Kemona, A; Namiot, DB; Namiot, Z | 1 |
Aoyama, N; Asaka, M; Fujioka, T; Fukuda, Y; Hirai, Y; Kuwayama, H; Sugiyama, T | 1 |
Almela, P; Aznárez, R; Benages, A; Borda, F; Bory, F; Calvet, X; Cañete, N; Castro, M; Cosme, A; Fernández, N; Feu, F; García-Grávalos, R; Gisbert, JP; Montoro, M; Pérez-Aisa, A; Piqué, JM; Santolaria, S | 1 |
Chen, TA; Chuah, SK; Hsu, PI; Lai, KH; Lin, WS; Lo, GH; Peng, NJ; Tsay, FW; Tseng, HH; Wu, CJ | 1 |
Bijlsma, JW; Boers, M; de Leest, HT; Dijkmans, BA; Houben, HH; Huisman, AM; Kadir, SW; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; van de Laar, MA; van Tulder, MW; Vonkeman, HE | 1 |
Fujioka, T; Furuta, T; Hishida, A; Kodaira, C; Murakami, K; Nakamura, A; Nishino, M; Okimoto, T; Okuda, M; Shirai, N; Soya, Y; Sugimoto, M | 1 |
Axon, AT; Crocombe, WD; Ford, AC; Forman, D; Moayyedi, P; Nathan, J | 1 |
Ahn, SB; Bang, SY; Eun, CS; Han, DS; Jeon, YC; Kang, JO; Kim, JE; Sohn, JH | 1 |
Choi, JH; Chun, HJ; Hyun, JJ; Jung, SW; Kim, CD; Kim, DI; Koo, JS; Lee, HS; Lee, SW; Park, JJ; Ryu, HS; Um, SH; Yim, HJ | 1 |
Hallas, J; Hansen, JM; Schaffalitzky de Muckadell, OB; Wildner-Christensen, M | 1 |
Börsch, G; Labenz, J | 1 |
Jaup, BH; Norrby, A | 1 |
Burette, A; Glupczynski, Y | 1 |
Celle, G; Mela, GS; Savarino, V; Vigneri, S | 1 |
Adamek, RJ; Opferkuch, W; Wegener, M | 1 |
Goddard, A; Logan, R | 1 |
Becker, T; Börsch, G; Labenz, J; Rühl, GH; Sollböhmer, M; Stolte, M; Tillenburg, B | 1 |
Gad, A; Unge, P | 1 |
Labenz, J | 2 |
al-Assi, MT; Genta, RM; Graham, DY; Karttunen, TJ | 1 |
al-Assi, MT; Genta, RM; Graham, DY; Lew, GM; Ramirez, FC | 1 |
Labenz, J; Stolte, M | 1 |
Adamek, RJ; Börsch, G; Labenz, J; Opferkuch, W; Rühl, GH; Wegener, M | 1 |
Nasu, M | 1 |
Axon, AT; Moayyedi, P; Sahay, P; Tompkins, DS | 1 |
Fujioka, T; Kawasaki, H; Kubota, T; Murakami, K; Nasu, M; Uribe, RU | 1 |
Buset, M; De Koster, E; Deltenre, M; Jonas, C; Otero, J; van Gossum, M | 1 |
Ido, K; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y; Yoshida, Y | 1 |
Hrruma, K; Kaji, M; Kajiyama, G; Mukai, T; Okamoto, S; Sumii, K; Uemura, N; Yamaguchi, S | 1 |
Bernards, S; Götz, JM; Lamers, CB; Veenendaal, RA; Veselic, M | 1 |
Carli, G; Dalla Libera, M; Gamberini, S; Gullini, S; Merighi, A; Pazzi, P; Scagliarini, R | 1 |
Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 1 |
Markham, A; McTavish, D | 1 |
Gabryelewicz, A | 1 |
Burette, A; Cozzoli, A; de Koster, E; Deltenre, M; Denis, P; Jonas, C; Otero, J | 1 |
Roesch, W | 1 |
Webb, DD | 1 |
Dammann, HG | 1 |
el-Zimaity, HM; Genta, RM; Graham, DY; Yousfi, MM | 1 |
Hackelsberger, A; Malfertheiner, P | 1 |
Cole, RA; El-Zimaity, HM; Genta, RM; Graham, DY; Yousfi, MM | 1 |
Dankert, J; ten Kate, FJ; Tytgat, GN; van der Ende, A; van der Hulst, RW; Weel, JF | 1 |
Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y | 1 |
Fukuda, Y; Shimoyama, T; Tamura, K; Tonokatsu, Y; Tsujiai, T | 1 |
Axon, AT; Chalmers, DM; Moayyedi, P | 1 |
Bortoli, A; Colombo, E; Imperiali, G; Lesinigo, E; Minoli, G; Spinzi, G; Terruzzi, V; Venturelli, R | 1 |
Hunt, RH; Sherman, PM; Veldhuyzen van Zanten, SJ | 1 |
Damianos, AJ; McGarrity, TJ | 1 |
Brenner, C; Ebell, MH; Warbasse, L | 1 |
Ebina, K; Kato, S; Naganuma, H; Takeyama, J | 1 |
Matsukura, N | 1 |
Barnett, JL; Chey, WD; DelValle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Scheiman, JM | 1 |
Breuer, T; el-Zimaity, HM; Graham, DY; Kim, JG; Nakajima, S; Nikajima, S; Osato, M; Ota, H | 1 |
Lal, S; Sheikh, RM; Zuberi, BF | 1 |
Attili, AF; Diana, F; Pugliano, F; Rinaldi, V; Zullo, A | 1 |
Adamek, RJ; Pfaffenbach, B; Szymanski, C | 1 |
Ando, H; Kagaya, T; Noda, Y; Takemori, Y | 1 |
Emami, S; Estrada, R; Laine, L; Trujillo, M | 1 |
Dixon, JS; Pipkin, GA; Williamson, R; Wood, JR | 1 |
Bhutta, AS; Bindel, H; Cunnane, K; Loane, J; O'Connor, HJ | 1 |
Boixeda de Miquel, D | 1 |
Fendrick, AM; Laine, L | 1 |
El-Zimaity, HM; Graham, DY; Kim, JG; Osato, MS; Perng, CL | 1 |
Johnsen, R; Lindsetmo, RO; Revhaug, A | 1 |
Cunnane, K; Kelly, S; Laundon, J; McLoughlin, R; O'Connor, HJ | 1 |
Scott, BB | 1 |
Blum, AL; Malfertheiner, P | 1 |
Huang, AH; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
Honda, T; Matsumoto, T; Mori, K; Nagatomi, Y; Takaba, M; Tsuneoka, H | 1 |
Fireman, Z; Kopelman, Y; Moshkowitz, M; Segal, A; Sternberg, A | 1 |
Fukuda, Y; Shimoyama, T; Tanida, N | 1 |
Kimura, K; Sato, K | 1 |
Aoyama, N | 1 |
Fujioka, T; Kubota, T; Murakami, K; Sato, R | 1 |
Hashimoto, Y | 1 |
Kleibeuker, JH; Kooy, A; Thijs, JC; van der Wouden, EJ; van Zwet, AA | 1 |
Bazzoli, F; Berretti, D; De Luca, L; Fossi, S; Nicolini, G; Pozzato, P; Ricciardiello, L; Zagari, M | 1 |
Filipowicz-Sosnowska, A; Gillon, KR; Hawkey, CJ; Lanas, A; Peacock, RA; Szczepanski, L; Tulassay, Z; van Rensburg, CJ; Wason, CM | 1 |
Kotze, D; Louw, JA; Marks, IN; Moola, S; Van Rensburg, CJ | 1 |
Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D | 1 |
Ho, B; Ho, KY; Hua, J; Ng, HC; Yeoh, KG | 1 |
De Fanis, C; Di Virgilio, M; Pantaleone, U; Pizzicanella, G; Russo, L; Sciampa, G; Silla, M; Spadaccini, A | 1 |
Howden, CW; Hunt, RH | 1 |
Chan, CC; Chen, TK; Huang, SH; Lee, CL; Lee, SC; Tu, TC; Wu, CH | 1 |
Arakawa, T; Kamisawa, T; Kato, H; Kozawa, H; Momma, K; Sakaki, N; Yamada, Y | 1 |
Garrido, A; Guerrero, FJ; Lepe, JA; Palomo, S | 1 |
Kimoto, M; Murakami, K | 1 |
Iijima, K; Kato, K; Ohara, S; Sekine, H | 1 |
Iwasaki, A | 1 |
Habu, Y; Inokuchi, H; Kiyota, K; Ko, K; Sugano, Y; Waki, S | 1 |
Harasawa, S; Kouda, K; Kurumada, T; Miwa, T; Shirai, T; Tada, U; Takagi, A; Wada, T; Watanabe, S | 1 |
Kawamura, N; Nakagawa, M; Nakagawa, S; Ooishi, M; Ooizumi, H; Saitou, M; Yoda, Y | 1 |
Kihira, K; Kimura, K; Kumakura, Y; Sato, K; Sugano, K; Yoshida, Y | 1 |
Goto, T; Hisiki, S; Kawaguchi, Y; Komatu, K; Siwa, T; Suzuki, R; Tanaka, M; Tochikubo, O; Yokoyama, N | 1 |
Navuluri, R; Yue, S | 1 |
Hu, PJ; Liu, WZ; Tytgat, GN; Xia, DH; Xiao, SD | 1 |
de Pablo, J; García, F; Gómez-Gil, E; Martínez, JA; Mensa, J; Pintor, L | 1 |
Miwa, H; Murai, T; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Shimizu, H; Watanabe, S | 1 |
Bozzola, L; Di Mario, F; Fortunato, A; Franceschi, M; Leandro, G; Meli, S; Pilotto, A; Rassu, M; Scagnelli, M; Soffiati, G; Valerio, G | 1 |
Jacoby, EB; Porter, KB | 1 |
Ducóns, JA; Ferrero, M; Gomollón, F; Guirao, R; Montoro, M; Santolaria, S | 1 |
Fuchs, W; Hörner, M; Schlauch, D; Sellinger, M; Sieg, A | 1 |
Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M | 1 |
Ende, AV; Hensen, EF; Hoff, BW; Houben, MH; Hulst, RW; Kate, FJ; Rauws, EA; Tytgat, GN | 1 |
Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Suen, R; Sung, JJ; Wu, JC | 1 |
Adler, G; Boeck, W; Ellenrieder, V; Glasbrenner, B; Marre, R; Richter, C | 1 |
Aoyama, N; Kasuga, M; Kita, T; Komada, F; Okumura, K; Shirakawa, K; Tanigawara, Y | 1 |
Ducóns, JA; Ferrero, M; García Cabezudo, J; Gomollón, F; Guirao, R; Montoro, M; Simón, MA | 1 |
Habu, Y; Inokuchi, H; Kawai, K; Kimoto, K; Kiyota, K; Mizuno, S; Sugano, Y | 1 |
Kasenõmm, P; Kolk, H; Lõivukene, K; Maaroos, HI; Mikelsaar, M; Ustav, M | 1 |
Beglinger, C; Drewe, J; Lehmann, FS; Terracciano, L | 1 |
Blackington, E | 1 |
Adamsson, I; Edlund, C; Nord, CE | 1 |
Boyanova, L; Katzarov, N; Koumanova, R; Mitov, I; Spassova, Z; Stancheva, I | 1 |
Azuma, T; Ito, S; Ito, Y; Kato, T; Kuriyama, M; Miyaji, H; Suto, H; Yamazaki, Y | 1 |
Baños, F; Burrull, M; Cabezas, C; Lafuente, C; Madridejos, R; Morera, R | 1 |
Axon, AT; Brown, J; Dowell, AC; Feltbower, R; Mason, J; Mason, S; Moayyedi, P; Nathan, J; Richards, ID | 1 |
Piqué, JM | 1 |
Hentschel, E | 1 |
Ducóns, JA; Ferrero, M; Gomollón, F; Revillo, MJ; Sicilia, B; Sierra, E | 1 |
Botta, F; Chiarbonello, B; Fasoli, A; Giannini, E; Lantieri, PB; Malfatti, F; Risso, D; Romagnoli, P; Savarino, V; Testa, R | 1 |
Ducóns, JA; Ferrero, M; Gomollón, F; Santolaria, S; Sicilia, B; Sierra, E | 1 |
Akagi, K; Hizawa, K; Inuzuka, S; Matsumoto, T; Nakahara, T; Yano, Y | 1 |
Cabezudo, JG; Ducóns, J; Gomollon, F; Guirao, R; Montoro, M; Santolaria, S | 1 |
Gisbert, JP; María Pajares, J | 1 |
Katelaris, PH | 1 |
Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Okimoto, T; Satoh, R | 1 |
Baik, SK; Cho, MY; Jeong, YS; Kim, HS; Kim, JW; Kim, KH; Kwon, SO; Lee, DK; Seo, JI | 1 |
Bastens, B; Delforge, M; Demoulin, JC; Fontaine, F; Gerard, A; Gillard, V; Lutgen, N | 1 |
Endo, H; Higuchi, S; Ohmi, N; Yoshida, H | 1 |
Gopanpallikar, A; Rathi, P; Sawant, P | 1 |
Avidan, B; Bar-Meir, S; Keller, N; Melzer, E | 1 |
Kölbel, CB; Lüth, S; Singer, MV; Teyssen, S | 1 |
Moayyedi, P; Murphy, B | 1 |
Kuipers, EJ; Kusters, JG | 1 |
Hojo, M; Miwa, H; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Yamada, T | 1 |
Chiba, N; Hunt, RH; Thomson, AB | 1 |
Bardhan, KD; Mitchell, TR; Morris, P; Morton, D; Perry, MJ; Roberts, PM; Rowland, A; Sanders, DS; Thompson, M | 1 |
Fedorov, AV; Sazhin, VP | 1 |
Gisbert, JP; Pajares, JM | 1 |
Bigard, MA | 1 |
Delchier, JC; Lamarque, D; Lascols, C; Soussy, CJ; Tankovic, J | 1 |
Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM | 1 |
Misawa, H; Miwa, H; Nagahara, A; Ohtaka, K; Sato, N; Yamada, T | 1 |
Ammon, S; Klotz, U; Treiber, G; van Doorn, LJ; Walker, S; Wittig, J | 1 |
Aoyama, N; Okumura, K; Shirasaka, D | 1 |
Sung, JJ; Wu, JC | 1 |
Khan, Z; Nair, P; O'Shea, C; Playford, RJ; Spiers, N; Wicks, AC | 1 |
Chi, CH; Huang, CC; Kao, AW; Sheu, BS; Wang, YL; Yang, HB | 1 |
Axon, AT; Brown, J; Crocombe, W; Drummond, M; Duffett, S; Feltbower, R; Forman, D; Mason, J; Mason, S; Moayyedi, P | 1 |
Malfertheiner, P; Pilotto, A | 1 |
Baena, JM; García, M; Hernández, MR; Hidalgo, A; Jiménez, S; López, C; Rams, F | 1 |
Fukuda, Y; Sakagami, T; Shimoyama, T; Yamamoto, N | 1 |
Nakamura, T | 1 |
Takeda, H | 1 |
Fu, HY; Kawano, S; Tanimura, H | 1 |
Sakaki, N | 1 |
Haruma, K; Kamada, T; Kusunoki, H | 1 |
Sawada, A | 1 |
Hiraishi, H; Kanke, K; Terano, A | 1 |
Azuma, T; Ito, S; Yamazaki, Y | 1 |
Fukuda, Y; Shimoyama, T | 1 |
Kiriyama, Y; Koizumi, K; Kuwayama, H; Ohara, T; Suga, M; Suzuki, K; Takahashi, M; Takata, H | 1 |
Baumann, R; Buri, P; Cunningham, M; Dederding, JP; Gallaz, L; Girard, L; Godin, N; Merki, H; Metry, JM; Sitavanc, R; Wermeille, J; Zelger, G | 1 |
Cuchí Burgos, E; Forné Bardera, M; Garau Alemany, J; Lite Lite, J; Quintana Riera, S | 1 |
Kolosovych, IV; Korotkyĭ, VM | 1 |
Azagra, R; Calvet, X; Cubells, MJ; Gené, E; López, T | 1 |
Ando, R; Hasegawa, M; Kawamura, M; Kobayashi, I; Muraoka, H; Nishida, M; Saika, T | 1 |
77 review(s) available for clarithromycin and Peptic Ulcer
Article | Year |
---|---|
V Spanish Consensus Conference on Helicobacter pylori infection treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2022 |
Updates to the Diagnosis and Clinical Management of Helicobacter pylori Infections.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 2023 |
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.
Topics: Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Probiotics; Reproducibility of Results; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome; Urea; Urease | 2014 |
[What is new in treating Helicobacter pylori infection?].
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Quinolones; Stomach Neoplasms | 2015 |
[Antibiomania: Think of the manic syndrome secondary to antibiotic therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Bipolar Disorder; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Peptic Ulcer | 2017 |
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; New Zealand; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Treatment Outcome | 2016 |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Metronidazole; Patient Compliance; Peptic Ulcer; Prevalence; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Singapore; Taiwan | 2016 |
[Helicobacter pylori -- 2010].
Topics: Age Factors; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carbonic Anhydrases; Clarithromycin; Disease Progression; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; History, 19th Century; History, 20th Century; Humans; Peptic Ulcer; Prevalence; Recurrence; Remission, Spontaneous; Urease | 2010 |
Diagnosis and treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Stomach Neoplasms; Tetracycline | 2011 |
[Helicobacter pylori eradication therapy in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2011 |
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors; Spain; Statistics as Topic; Time Factors; Treatment Outcome | 2011 |
[Helicobacter pylori - 2012].
Topics: Algorithms; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Emigrants and Immigrants; Endoscopy, Gastrointestinal; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; In Situ Hybridization, Fluorescence; Levofloxacin; Ofloxacin; Peptic Ulcer; Polymerase Chain Reaction; Stomach Neoplasms | 2012 |
Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Gene Expression Regulation, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms; Virulence | 2012 |
[Clinical features of peptic ulcer disease in the elderly].
Topics: Aged; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Peptic Ulcer | 2002 |
[The treatment of peptic ulcer in elderly CRF patients].
Topics: Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Clarithromycin; Helicobacter Infections; Histamine H2 Antagonists; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
Treatment and management of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Cardiovascular Diseases; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Rabeprazole; Stomach Neoplasms; Treatment Outcome | 2002 |
[Helicobacter pylori. Update 2002].
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Follow-Up Studies; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Risk; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Time Factors | 2002 |
[Guidelines in the management of Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Microbiology; Omeprazole; Peptic Ulcer; Polyps; Practice Guidelines as Topic; Proton Pump Inhibitors; Societies, Medical; Stomach Neoplasms | 2003 |
Is it time for quadruple therapy to be first line?
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2003 |
Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Apoptosis; Chemistry, Clinical; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Japan; Lansoprazole; Omeprazole; Peptic Ulcer; Urease | 2003 |
[What is Helicobacter pylori?: associated diseases in human].
Topics: Amoxicillin; Animals; Clarithromycin; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms | 2004 |
[The several problems and cautions in treatment of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastric Acid; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors; Secondary Prevention; Stomach Neoplasms | 2004 |
[Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2004 |
[Helicobacter pylori: reasons for eradication].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Secondary Prevention; Stomach Neoplasms | 2004 |
A clinician's guide to managing Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Endoscopy; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer | 2005 |
[Diagnosis of and therapy for peptic ulcer].
Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Hemostasis, Endoscopic; Histamine H2 Antagonists; Humans; Japan; Omeprazole; Peptic Ulcer; Practice Guidelines as Topic; Proton Pump Inhibitors; Stress, Psychological; Sucralfate | 2005 |
[Generalization of Helicobacter pylori eradication therapy and its future in Japan].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Purpura, Thrombocytopenic, Idiopathic | 2006 |
Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Peptic Ulcer; Treatment Outcome; Uncoupling Agents | 1995 |
Antibacterial therapy of Helicobacter pylori-associated peptic ulcer disease: a new strategy. The Swedes go for it.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1994 |
[Helicobacter pylori therapy with omeprazole and clarithromycin: current status].
Topics: Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic | 1994 |
[Current therapy of Helicobacter pylori infection].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Recurrence | 1994 |
[Helicobacter pylori infections].
Topics: Amphotericin B; Bismuth; Clarithromycin; Drug Resistance, Microbial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Tetracyclines | 1993 |
Clarithromycin and omeprazole as helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1996 |
Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Tetracyclines; Tinidazole | 1996 |
Strategies for Helicobacter pylori eradication in 1995: a review of international and Belgian experience.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Belgium; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Treatment Outcome | 1996 |
Cost-effectiveness of H. pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Markov Chains; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms; Treatment Outcome | 1996 |
[Helicobacter pylori eradication: triple therapy versus dual therapy].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline; Tinidazole; Treatment Outcome | 1996 |
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Risk Assessment; Tetracyclines | 1996 |
Efficacy of clarithromycin in eradicating Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer | 1996 |
Helicobacter pylori: new developments and treatments.
Topics: Algorithms; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1997 |
Treatment strategies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Salicylates; Tetracycline | 1997 |
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
Topics: Amoxicillin; Antitrichomonal Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Tinidazole | 1997 |
Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Ranitidine | 1997 |
Helicobacter pylori and peptic ulcer disease. Bridging the gap between knowledge and treatment.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1998 |
[Helicobacter pylori infection and ulcer].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Treatment Outcome; Virulence | 1998 |
[Antibiotic therapy in eradicating Helicobacter pylori infections].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Penicillins; Peptic Ulcer; Primary Health Care; Proton Pump Inhibitors | 1998 |
[Recent topics on Helicobacter pylori--Historic background and problems caused by bacteria].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Peptic Ulcer; Proton Pump Inhibitors | 1998 |
[Efficacy of antibiotic therapy in eradicating Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms | 1998 |
[Problems following antibiotic therapy for eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Esophagitis, Peptic; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer | 1998 |
Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Selection; Penicillins; Peptic Ulcer; Randomized Controlled Trials as Topic | 1998 |
[Antibiotic-resistant H. pylori strains in the last ten years in Japan].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Penicillin Resistance; Penicillins; Peptic Ulcer; Time Factors | 1999 |
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors | 1999 |
The gastric demon. An update on Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Nurse Practitioners; Peptic Ulcer; Risk Factors; Sensitivity and Specificity; Stomach Neoplasms | 1999 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastric Mucosa; Gastritis; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms | 2000 |
[Treatment of Helicobacter pylori infections].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Practice Guidelines as Topic; Ranitidine; Stomach Neoplasms | 2000 |
[Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Spain | 2001 |
[Selection of antibiotics and planning of eradication for H. pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2001 |
Helicobacter pylori: a clinical update.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2001 |
Antibiotic resistance of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Penicillins; Peptic Ulcer; Tetracycline | 2001 |
Ranitidine bismuth citrate.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter pylori; Humans; Peptic Ulcer; Ranitidine | 2001 |
Helicobacter pylori therapy: first-line options and rescue regimen.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Salvage Therapy; Treatment Outcome | 2001 |
[Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Stomach Neoplasms | 2001 |
[Progress of tailor-made treatment of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
Ulcer and gastritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Precancerous Conditions; Proton Pump Inhibitors; Rifabutin; Stomach Neoplasms | 2002 |
Review article: an approach to Helicobacter pylori infection in the elderly.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Peptic Ulcer; Treatment Failure | 2002 |
[Development of Helicobacter pylori eradication therapy].
Topics: Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[The outline of medical treatment of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Current role of acid suppressants in the treatment of peptic ulcer disease].
Topics: Amoxicillin; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Dual therapy for Helicobacter pylori resistance to anti microbial agents].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2002 |
[Acute mucosal lesion of the upper-gastrointestinal tract observed after H. pylori-eradication].
Topics: Acute Disease; Amoxicillin; Clarithromycin; Esophagitis, Peptic; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Omeprazole; Peptic Ulcer | 2002 |
[H. pylori eradication therapy and natural history of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Secondary Prevention | 2002 |
[Peptic ulcer in the elderly].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Sucralfate].
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Sucralfate; Treatment Outcome; Urease | 2002 |
[Plaunotol].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Resistance, Bacterial; Drug Therapy, Combination; Fatty Alcohols; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Neutrophil Activation; Omeprazole; Peptic Ulcer; Prognosis | 2002 |
[Sofalcone].
Topics: Amoxicillin; Anti-Ulcer Agents; Chalcone; Chalcones; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Treatment Outcome | 2002 |
[Polaprezinc].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Carnosine; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Urease; Zinc Compounds | 2002 |
136 trial(s) available for clarithromycin and Peptic Ulcer
Article | Year |
---|---|
Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial.
Topics: Aged; Anti-Bacterial Agents; Aspirin; Clarithromycin; Drug Therapy, Combination; Helicobacter; Helicobacter Infections; Helicobacter pylori; Hot Temperature; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Primary Health Care; Primary Prevention | 2022 |
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Topics: Adult; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Prospective Studies; Quinolones; Treatment Outcome | 2018 |
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome | 2018 |
[Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Peptic Ulcer; Stomach Neoplasms; Taiwan | 2013 |
Penbactam for Helicobacter pylori eradication: a randomised comparison of quadruple and triple treatment schedules in an Iranian population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Sulbactam; Urea; Young Adult | 2013 |
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome; Urea; Young Adult | 2014 |
Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenoscopy; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2013 |
Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Pantoprazole; Peptic Ulcer; Tinidazole | 2015 |
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Ribosomal; Drug Therapy, Combination; Female; Gastritis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Probiotics; Proton Pump Inhibitors; Sequence Analysis, DNA; Stomach Neoplasms | 2016 |
Impact of creatinine clearance on Helicobacter pylori eradication rate in patients with peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Creatinine; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 2015 |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome; Young Adult | 2016 |
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2016 |
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyloric Antrum; Urea | 2016 |
Adjunctive Therapy with Curcumin for Peptic Ulcer: a Randomized Controlled Trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Curcumin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter pylori; Humans; Male; Pantoprazole; Peptic Ulcer | 2016 |
[Interleukin-1beta gene polymorphism as a predictor of eradication treatment efficacy in gastric and duodenal ulcer associated with Helicobacter pylori].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Endoscopy, Digestive System; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1beta; Middle Aged; Omeprazole; Peptic Ulcer; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prospective Studies; Treatment Outcome; Young Adult | 2008 |
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Stomach Neoplasms; Young Adult | 2009 |
[Effect of CYP2C19 gene polymorphism on eradication treatment efficacy of Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Breath Tests; Clarithromycin; Cohort Studies; Cytochrome P-450 CYP2C19; DNA; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metabolic Clearance Rate; Moscow; Omeprazole; Peptic Ulcer; Polymorphism, Single Nucleotide; Prospective Studies | 2009 |
Sequential metronidazole-furazolidone or clarithromycin-furazolidone compared to clarithromycin-based quadruple regimens for the eradication of Helicobacter pylori in peptic ulcer disease: a double-blind randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Young Adult | 2010 |
Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Probiotics; Single-Blind Method; Treatment Outcome; Urea; Young Adult | 2011 |
Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Brazil; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome | 2010 |
Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Peptic Ulcer; Prospective Studies; Rifamycins; Rifaximin | 2011 |
Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Rabeprazole; Republic of Korea; Time Factors; Treatment Outcome | 2012 |
Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Esomeprazole; Female; Greece; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Prospective Studies | 2012 |
[Enterofuril eradication therapy in chronic inflammatory diseases of the upper digestive tract].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Infective Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Hydroxybenzoates; Male; Metronidazole; Nitrofurans; Pantoprazole; Peptic Ulcer; Treatment Outcome | 2011 |
Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Middle Aged; Pantoprazole; Peptic Ulcer; Prospective Studies; Tinidazole; Treatment Outcome | 2013 |
Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; DNA; Drug Therapy, Combination; Enzyme Inhibitors; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2002 |
One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline; Treatment Outcome | 2002 |
Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
Topics: Adult; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pain; Peptic Ulcer; Treatment Outcome | 2002 |
The effects of nocturnal acid breakthrough on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Circadian Rhythm; Clarithromycin; Drug Therapy, Combination; Female; Gastric Acid; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Treatment Outcome | 2002 |
Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Prospective Studies; Ranitidine; Stomach; Thailand; Treatment Outcome | 2002 |
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Cytochrome P-450 Enzyme System; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2003 |
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure; Treatment Outcome | 2003 |
Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Safety | 2003 |
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2003 |
Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Sweden; White People | 2003 |
Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tinidazole; Treatment Outcome | 2003 |
[A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Rabeprazole | 2003 |
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Peptic Ulcer; Secondary Prevention; Treatment Outcome | 2003 |
Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome | 2003 |
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides; Treatment Outcome | 2003 |
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2003 |
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; DNA; Drug Evaluation; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Polymerase Chain Reaction; Rabeprazole; Risk Factors; Smoking; Tinidazole; Treatment Outcome | 2004 |
[Efficacy of anti-Helicobacter therapy in children with ulcer-like functional dyspepsia].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2003 |
Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2003 |
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibody Specificity; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Genetic Predisposition to Disease; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Omeprazole; Patient Compliance; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Proton Pumps; Treatment Outcome | 2004 |
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Prospective Studies; Tinidazole; Treatment Outcome; Wound Healing | 2004 |
The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Rabeprazole; Smoking; Tinidazole; Treatment Outcome | 2004 |
The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tinidazole; Treatment Outcome | 2004 |
Helicobacter pylori eradication decreases blood neutrophil and monocyte counts.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Leukocyte Count; Leukocytes, Mononuclear; Male; Middle Aged; Neutrophils; Omeprazole; Peptic Ulcer; Retrospective Studies | 2004 |
Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Recurrence; Wound Healing | 2005 |
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Chalcone; Chalcones; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole | 2005 |
Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Peptic Ulcer; RNA, Ribosomal, 23S; Treatment Outcome | 2005 |
Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2005 |
Effect of high-dose aspirin on Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects | 2005 |
[Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 2005 |
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Rabeprazole; Treatment Outcome | 2005 |
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome | 2005 |
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2005 |
[Five-day rabeprazole-based triple therapy for helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Furazolidone; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Rabeprazole | 2004 |
Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Recurrence; Tinidazole; Treatment Outcome | 2005 |
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Patient Compliance; Peptic Ulcer; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome | 2005 |
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Needs Assessment; Omeprazole; Peptic Ulcer; Probability; Reference Values; Rheumatic Diseases; Risk Assessment; Statistics, Nonparametric; Treatment Outcome | 2005 |
Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Patient Acceptance of Health Care; Peptic Ulcer; Quality of Life; Ranitidine | 2006 |
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2006 |
[Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Russia; Tetracycline; Treatment Outcome | 2005 |
[Double blind randomized multicentre study of a seven-day eradication regime of Helicobacter pylori by omeprazole, clarithromycin and ornidazole vs. omeprazole, clarithromycin and metronidazole].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Ornidazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Prospective Studies; Ranitidine | 2006 |
Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mouth Mucosa; Omeprazole; Oral Hygiene; Peptic Ulcer; Tinidazole; Treatment Outcome | 2007 |
Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2007 |
Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Time Factors; Treatment Outcome | 2007 |
High-dose versus low-dose esomeprazole-based triple therapy for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Pilot Projects; Prospective Studies; Treatment Outcome | 2007 |
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Middle Aged; Omeprazole; Peptic Ulcer; Time Factors; Treatment Outcome | 2007 |
Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.
Topics: Adult; Alkylating Agents; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Tinidazole | 2007 |
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Community Health Services; Cost-Benefit Analysis; Cross-Sectional Studies; Denmark; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2008 |
Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome | 1995 |
One-week low-dose triple therapy for the eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1995 |
Clarithromycin-amoxycillin therapy for Helicobacter pylori infection.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Pyloric Antrum; Ranitidine | 1994 |
[Omeprazole modified antibiotic therapy of Helicobacter pylori infection: can clarithromycin be replaced by roxithromycin?].
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Roxithromycin | 1994 |
Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Single-Blind Method; Tinidazole | 1995 |
Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer | 1995 |
Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer | 1995 |
Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Recurrence | 1995 |
Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Middle Aged; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome | 1995 |
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer | 1996 |
Therapeutic options after failed Helicobacter pylori eradication therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Retreatment; Treatment Failure | 1996 |
Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer | 1997 |
Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; Child; Chronic Disease; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Acid; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Peptic Ulcer; Pyloric Antrum; Treatment Outcome | 1997 |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Dyspepsia; Evaluation Studies as Topic; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Taste Disorders | 1997 |
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Korea; Male; Middle Aged; Nizatidine; Penicillins; Peptic Ulcer | 1997 |
Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Tetracycline; Tinidazole | 1997 |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Sulfoxides | 1997 |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Salicylates; Tetracycline; Urea | 1997 |
One week triple therapy for Helicobacter pylori: does high-dose clarithromycin confer additional benefit?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Patient Compliance; Peptic Ulcer; Taste Disorders; Time Factors; Treatment Outcome; Treatment Refusal | 1997 |
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Recurrence; Vagotomy | 1998 |
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Diarrhea; Drug Therapy, Combination; Endoscopes; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Taste Disorders; Time Factors; Treatment Outcome | 1998 |
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anus Diseases; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Diarrhea; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hallucinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Omeprazole; Peptic Ulcer; Pregnancy; Protein Synthesis Inhibitors; Proton Pump Inhibitors; Taste Disorders; Time Factors; Tongue Diseases; Treatment Outcome; Urea; Vomiting | 1998 |
One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Treatment Failure | 1998 |
[Eradication therapies for Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Tinidazole | 1998 |
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Time Factors; Treatment Failure | 1998 |
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Life Tables; Male; Middle Aged; Omeprazole; Peptic Ulcer; Recurrence; Risk Factors | 1998 |
Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1998 |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton-Translocating ATPases; Rabeprazole; Time Factors; Treatment Outcome | 1998 |
Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine; Time Factors; Tinidazole | 1998 |
Preliminary study on a novel quadruple eradication therapy with a mucoprotective drug, sofalcone, for Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chalcone; Chalcones; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Treatment Outcome | 1998 |
[Recurrence rate of H. pylori after successful eradication and second eradication therapy after initial failure of treatment].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Recurrence; Time Factors; Treatment Failure | 1999 |
[Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1999 |
[Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 1999 |
[A comparative study; one week treatment versus two weeks treatment with lansoprazol, amoxycillin and clarythromycin for the eradication of Helicobacter pylori in patient with gastric and duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Treatment Outcome | 1999 |
[Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 1999 |
[Erosive duodenitis after eradication therapy for Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenitis; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Peptic Ulcer | 1999 |
High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors | 1999 |
Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Time Factors | 1999 |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome | 1999 |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Single-Blind Method | 1999 |
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome | 1999 |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Peptic Ulcer; Prospective Studies; Statistics, Nonparametric; Sulfoxides; Treatment Failure | 1999 |
Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Single-Blind Method; Time Factors; Treatment Outcome | 1999 |
Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ornidazole; Penicillins; Peptic Ulcer; Treatment Outcome | 2000 |
Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2000 |
[Effectiveness of omeprazole, clarithromycin and amoxycillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer. Preliminary results of GENPY study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Treatment Outcome | 2000 |
Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.
Topics: Adult; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Omeprazole; Peptic Ulcer; Quality of Life; Sickness Impact Profile; Tinidazole | 2000 |
Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Patient Compliance; Peptic Ulcer; Prospective Studies; Urea | 2000 |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Radioisotopes; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides | 2000 |
Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Capsules; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Tablets | 2001 |
Comparison of two regimens on eradication of Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Tinidazole | 2000 |
The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Patient Selection; Penicillins; Peptic Ulcer; Time Factors; Treatment Failure | 2001 |
Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome; Urea; Urease | 2001 |
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Omeprazole; Peptic Ulcer | 2001 |
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Peptic Ulcer; Ranitidine; Retrospective Studies | 2001 |
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Regression Analysis; Treatment Outcome | 2002 |
Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding.
Topics: Administration, Oral; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillins; Peptic Ulcer; Ranitidine; Recurrence; Treatment Outcome; Urea | 2002 |
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Dyspepsia; Female; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Male; Markov Chains; Mass Screening; Middle Aged; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Risk Factors; Tinidazole | 2002 |
Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week.
Topics: Adult; Aged; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Smoking; Time Factors | 2002 |
121 other study(ies) available for clarithromycin and Peptic Ulcer
Article | Year |
---|---|
A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Coronary Disease; Disease Progression; Helicobacter pylori; Humans; Peptic Ulcer | 2022 |
Clinical effect of Anwei Qingyou recipe on peptic ulcer and its effect on the levels of EGF and PGE2: A retrospective study.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dinoprostone; Drug Therapy, Combination; Epidermal Growth Factor; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Retrospective Studies | 2022 |
Antibiotic Resistance of
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Microbial; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Tetracycline; Ulcer | 2022 |
Antibiotic resistance of Helicobacter pylori infection in a children's hospital in Vietnam: prevalence and associated factors.
Topics: Amoxicillin; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Peptic Ulcer; Tetracycline; Vietnam | 2020 |
Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies | 2020 |
Antimicrobial Resistance and the Successful Eradication of
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Child, Preschool; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Tetracycline | 2021 |
Low rate of recurrence of Helicobacter pylori infection in spite of high clarithromycin resistance in Pakistan.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pakistan; Peptic Ulcer; Prevalence; Recurrence; Treatment Outcome; Young Adult | 2013 |
Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Acidity Determination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2013 |
What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Breath Tests; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Stomach; Tetracycline; Treatment Outcome; Urea; Young Adult | 2013 |
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Chlorides; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Peptic Ulcer; Salicylates; Zinc Compounds | 2014 |
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].
Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Bismuth; Breath Tests; Clarithromycin; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metaplasia; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms; Tetracycline | 2013 |
Decreasing efficacy of the standard seven-day triple therapy containing amoxycillin and clarithromycin in curing Helicobacter pylori infection in clinical setting in Italy: a 10-year follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Endoscopy; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Time Factors; Treatment Outcome | 2014 |
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype.
Topics: Adult; Aged; Anti-Bacterial Agents; Asian People; Base Sequence; China; Clarithromycin; Cluster Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minority Groups; Molecular Sequence Data; Mutation; Peptic Ulcer; Phenotype; Polymerase Chain Reaction; Ribotyping; Treatment Outcome | 2014 |
The Helicobacter pylori resistance rate to clarithromycin in Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Base Sequence; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mutation, Missense; Peptic Ulcer; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 23S; Young Adult | 2015 |
[Progress in the treatment of Helicobacter pylori infection].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Drugs, Chinese Herbal; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Metronidazole; Peptic Ulcer; Probiotics; Stomach Neoplasms | 2014 |
A 15-year-old boy with abdominal pain, growth retardation, and anemia secondary to Helicobacter pylori-associated peptic ulcer.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Clarithromycin; Drug Therapy, Combination; Growth Disorders; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2015 |
Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Moxifloxacin; Peptic Ulcer; Risk Factors; Young Adult | 2015 |
Pneumobilia with gastric outlet obstruction.
Topics: Amoxicillin; Anti-Bacterial Agents; Biliary Tract Diseases; Clarithromycin; Esomeprazole; Gastric Bypass; Gastric Outlet Obstruction; Humans; Intestinal Fistula; Male; Middle Aged; Peptic Ulcer; Postprandial Period; Proton Pump Inhibitors; Treatment Outcome; Vomiting; Weight Loss | 2015 |
[Quadruple therapy is more effective against H. pylori].
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors | 2016 |
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; RNA, Ribosomal, 23S; Sulfonamides; Treatment Outcome; Urea | 2016 |
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Body Mass Index; Body Weight; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis, Atrophic; Ghrelin; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Leptin; Male; Middle Aged; Peptic Ulcer | 2016 |
[Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2008 |
H. pylori should be eradicated in chronic liver disease patients with peptic ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Helicobacter Infections; Helicobacter pylori; Hepatitis, Chronic; Humans; Liver Cirrhosis; Peptic Ulcer; Proton Pump Inhibitors; Research Design; Treatment Outcome | 2009 |
Antibiotic susceptibility patterns in Helicobacter pylori strains from patients with upper gastrointestinal pathology in western Nigeria.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Nigeria; Peptic Ulcer; Polymerase Chain Reaction; Stomach; Tetracycline | 2009 |
[Antihelicobacteric therapy for the patients with recurrent complicated postoperative gastroduodenal ulcer: indications, principles of conduction, efficacy].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Recurrence; Treatment Outcome | 2009 |
Drug resistance pattern and clonality in H. pylori strains.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents, Local; beta-Lactamases; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Tetracycline | 2009 |
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Enzyme-Linked Immunosorbent Assay; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms; Tetracycline | 2009 |
Case report: peptic ulcer disease in a professional athlete.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Football; Humans; Male; Medical History Taking; Omeprazole; Peptic Ulcer; Risk Factors; Young Adult | 2009 |
Correlation of CYP2C19 genetic polymorphisms with helicobacter pylori eradication in patients with cirrhosis and peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Liver Cirrhosis; Male; Middle Aged; Peptic Ulcer; Polymorphism, Genetic; Rabeprazole | 2010 |
Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Point Mutation; Polymerase Chain Reaction; Prospective Studies; Tunisia; Young Adult | 2010 |
Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children.
Topics: Adolescent; Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Decision Trees; Drug Resistance, Bacterial; Drug Therapy, Combination; Europe; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Infant, Newborn; North America; Peptic Ulcer; Proton Pump Inhibitors; Young Adult | 2011 |
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2011 |
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.
Topics: Adult; Algorithms; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metaplasia; Middle Aged; Multiphasic Screening; Odds Ratio; Peptic Ulcer; Precancerous Conditions; Prevalence; Recurrence; Risk Factors; Stomach Neoplasms; Taiwan; Treatment Outcome | 2013 |
Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Singapore; Treatment Outcome; Young Adult | 2013 |
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2002 |
Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates.
Topics: Anti-Bacterial Agents; Binding, Competitive; Clarithromycin; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Epithelial Cells; Gastric Mucosa; Gastrointestinal Motility; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Stomach; Treatment Outcome; Urease | 2002 |
Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Rabeprazole; Tinidazole | 2002 |
A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunologic Tests; Male; Middle Aged; Omeprazole; Pepsinogen A; Peptic Ulcer; Rabeprazole; Reagent Kits, Diagnostic; ROC Curve; Sensitivity and Specificity | 2002 |
[Association among anti-CagA antibody detection, antibiotic susceptibility, and peptic ulcer in patients with Helicobacter pylori infection].
Topics: Adult; Aged; Antibodies, Bacterial; Antibody Specificity; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Prognosis; Virulence | 2003 |
Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Cross-Sectional Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine | 2003 |
Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides | 2003 |
Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases.
Topics: Anti-Bacterial Agents; Asian People; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Point Mutation; RNA, Bacterial | 2003 |
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Pharmacogenetics; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Treatment Outcome | 2003 |
A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Creatinine; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Retrospective Studies | 2003 |
Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study.
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; India; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Tetracycline | 2003 |
A case of clarithromycin-induced manic episode (antibiomania).
Topics: Anti-Bacterial Agents; Bipolar Disorder; Clarithromycin; Female; Humans; Middle Aged; Peptic Ulcer | 2004 |
Tinnitus due to clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Hearing Loss, Bilateral; Humans; Male; Middle Aged; Peptic Ulcer; Tinnitus | 2003 |
[Long-term course of reflux symptoms following Helicobacter pylori eradication].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Esophagitis, Peptic; Female; Follow-Up Studies; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Omeprazole; Peptic Ulcer; Prospective Studies; Time Factors | 2004 |
Micro-broth dilution method with air-dried microplate for determining MICs of clarithromycin and amoxycillin for Helicobacter pylori isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Culture Media; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Peptic Ulcer; Reference Standards | 2004 |
Growth competition of macrolide-resistant and -susceptible Helicobacter pylori strains.
Topics: Anti-Infective Agents; Base Sequence; Clarithromycin; Clone Cells; DNA, Bacterial; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2004 |
[Clarithromycin resistance of Helicobacter pylori strains isolated from antral biopsy specimens].
Topics: Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Pyloric Antrum | 2004 |
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; CD55 Antigens; CD59 Antigens; Clarithromycin; Complement C3c; Complement Inactivator Proteins; Complement System Proteins; Female; Gastric Mucosa; Gastritis; Glycosylphosphatidylinositols; Helicobacter Infections; Helicobacter pylori; Humans; Male; Membrane Cofactor Protein; Middle Aged; Omeprazole; Peptic Ulcer; Receptors, Complement | 2005 |
CagA status and Helicobacter pylori eradication among dyspeptic patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Biomarkers; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme-Linked Immunosorbent Assay; Eosinophilia; Eosinophils; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphocytes; Male; Middle Aged; Omeprazole; Peptic Ulcer | 2005 |
[Prevalence of Helicobacter pylori resistant to clarithromycin, amoxicillin and metronidazole in children].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Gastroscopy; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Prevalence | 2004 |
Helicobacter pylori: factors affecting eradication and recurrence.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biological Availability; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Sulfoxides | 2005 |
Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Middle Aged; Peptic Ulcer; Polymerase Chain Reaction; Prevalence | 2006 |
Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline | 2006 |
[Medical, social, and economic effectiveness of treatment of day-case patients with peptic ulcer].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenum; Esophagus; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Stomach | 2006 |
Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe.
Topics: Adolescent; Age Distribution; Amoxicillin; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Peptic Ulcer; Prospective Studies; Sex Distribution; Treatment Failure | 2006 |
Helicobacter pylori eradication in peptic dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2005 |
Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; China; Clarithromycin; Cohort Studies; Cost-Benefit Analysis; Diclofenac; Drug Administration Schedule; Female; Health Care Costs; Health Services; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Risk Factors | 2006 |
Eradication of Helicobacter pylori and dosages of esomeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Patient Compliance; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome | 2006 |
Helicobacter pylori antibiotic resistance in a Dutch region: trends over time.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Netherlands; Peptic Ulcer; Proton Pump Inhibitors; Time Factors | 2006 |
Guidelines in the medical treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Dyspepsia; Europe; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors | 2006 |
Analysis of resistance to clarithromycin and iceA status in Helicobacter pylori isolates from San Luis, Argentina.
Topics: Argentina; Bacterial Outer Membrane Proteins; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Peptic Ulcer; Point Mutation; RNA, Ribosomal, 23S; Stomach Neoplasms | 2006 |
Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; DNA Primers; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Peptic Ulcer; Phenotype; Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2007 |
[Pathogen eradication prevents gastrointestinal complications].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Long-Term Care; Peptic Ulcer; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Premedication; Proton Pump Inhibitors; Risk Factors; Secondary Prevention | 2007 |
[Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Retrospective Studies | 2007 |
Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Topics: Adult; Alanine Transaminase; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Hepatitis, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2009 |
Toward an optimal treatment of Helicobacter pylori-positive peptic ulcers.
Topics: Bismuth; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1995 |
Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Tinidazole | 1995 |
Helicobacter pylori eradication and reinfection.
Topics: Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Omeprazole; Peptic Ulcer; Ranitidine | 1995 |
One-week low-dose triple therapy: new standards for Helicobacter pylori treatment.
Topics: Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tinidazole | 1995 |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline; Time Factors | 1994 |
Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Penicillins; Peptic Ulcer; Prospective Studies; Recurrence | 1995 |
High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Tinidazole | 1996 |
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies | 1996 |
Practice guidelines for treatment of peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Peptic Ulcer; Practice Guidelines as Topic; Ranitidine | 1996 |
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Stomach Ulcer | 1996 |
Eradication of Helicobacter pylori followed by reinfection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Blotting, Southern; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillins; Peptic Ulcer; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Recurrence | 1996 |
Drugs for treatment of peptic ulcers.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Interactions; Drug Resistance, Microbial; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Misoprostol; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Salicylic Acid; Sucralfate; Tetracycline | 1997 |
Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Regression Analysis; Sex Factors; Smoking; Tinidazole; Treatment Failure | 1997 |
[Helicobacter pylori eradication: finally clarity].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer | 1996 |
Evaluation of the dyspeptic patient: a cost-utility study.
Topics: Adult; Ambulatory Care; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Barium Sulfate; Clarithromycin; Contrast Media; Cost-Benefit Analysis; Decision Support Techniques; Dyspepsia; Endoscopy, Gastrointestinal; Evaluation Studies as Topic; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Probability; Quality of Life; Recurrence; Survival Rate; Treatment Outcome; Value of Life | 1997 |
[Two step therapy for education of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 1997 |
Low dose, short-term, triple therapy for helicobacter pylori associated peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Peptic Ulcer | 1997 |
[Changes in serum anti-Helicobacter pylori IgG antibody, pepsinogen I, and pepsinogen II after eradication therapy of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Penicillins; Pepsinogens; Peptic Ulcer; Proton Pump Inhibitors | 1997 |
[Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Stomach Ulcer; Time Factors; Tinidazole | 1997 |
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Lansoprazole; Male; Metronidazole; Omeprazole; Peptic Ulcer; Time Factors | 1998 |
[Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillin Resistance; Penicillins; Peptic Ulcer | 1998 |
Helicobacter pylori and peptic ulcer disease therapies: a survey of gastroenterologists in Israel.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Health Care Surveys; Helicobacter pylori; Humans; Israel; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Tinidazole | 1998 |
Characterization of clinical isolates of Helicobacter pylori in Singapore.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Bacterial Typing Techniques; Biopsy; Clarithromycin; Cytotoxins; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Prevalence; Random Amplified Polymorphic DNA Technique; Singapore; Stomach; Tetracycline Resistance | 1998 |
Treating Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine | 1998 |
One-week low-dose triple therapy is effective in treating Helicobacter pylori-infected patients with bleeding peptic ulcers.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1998 |
[Eradication of Helicobacter pylori by triple therapy in ulcerous patients: the role of endoscopy and antibiotic sensitivity].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastrointestinal Agents; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer | 1998 |
Understanding peptic ulcer disease pharmacotherapeutics.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1999 |
Clarithromycin-induced acute psychoses in peptic ulcer disease.
Topics: Acute Disease; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Peptic Ulcer; Psychoses, Substance-Induced | 1999 |
Helicobacter pylori infection and persistent hyperemesis gravidarum.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hyperemesis Gravidarum; Omeprazole; Penicillins; Peptic Ulcer; Pregnancy; Pregnancy Complications, Infectious; Proton Pump Inhibitors; Ranitidine | 1999 |
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies | 1999 |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein Synthesis Inhibitors; Treatment Outcome | 1999 |
Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia.
Topics: Adolescent; Adult; Aerobiosis; Aged; Anaerobiosis; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Female; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Polymerase Chain Reaction; Stomach Ulcer; Virulence | 2000 |
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bulgaria; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Stomach; Tetracycline | 2000 |
[Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Primary Health Care; Tetracycline | 2000 |
Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastritis; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer | 2000 |
Effect of amoxicillin, clarithromycin, and rabeprazole, a new proton pump inhibitor, in eradication therapy for relapsing peptic ulcer diseases with Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Recurrence | 2000 |
Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Peptic Ulcer; Ranitidine | 2001 |
Helicobacter pylori: changing patterns of ulcer disease and antibiotic resistance.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Australia; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer | 2000 |
[Prevalence and treatment of Helicobacter pylori in gastro-duodenal ulcers. An experience in Liege].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Belgium; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prevalence; Prospective Studies; Treatment Outcome; Urban Population | 2001 |
Effects of lansoprazole, clarithromycin and pH gradient on uptake of [14C]amoxycillin into rat gastric tissue.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Biological Transport; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Duodenum; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Penicillins; Peptic Ulcer; Rats; Rats, Wistar | 2001 |
4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects; Rabeprazole | 2001 |
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Recurrence; Retrospective Studies; Treatment Failure | 2001 |
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Laparoscopy; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Postoperative Complications; Ranitidine; Recurrence; Stomach Ulcer; Tetracycline; Time Factors | 2001 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastric Fundus; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pyloric Antrum; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |
Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Polymorphism, Genetic; Prospective Studies; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2001 |
Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study.
Topics: Amoxicillin; Antacids; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Gastroduodenal ulcer in childhood].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Informed Consent; Japan; Lansoprazole; Male; Omeprazole; Peptic Ulcer; Practice Guidelines as Topic; Treatment Failure | 2002 |
Failure of Helicobacter pylori eradication: is poor compliance the main cause?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Peptic Ulcer; Treatment Failure | 2002 |
[Evolution of the sensitivity of 235 strains of Helicobacter pylori from 1995 to 1998 and impact of antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Spain; Tetracycline | 2002 |
[Pharmacotherapeutic aspects of early postoperative period in patients with complicated gastroduodenal ulcer].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Combined Modality Therapy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Postoperative Period; Proton Pumps; Tinidazole; Vagotomy | 2002 |
[Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Primary Health Care; Surveys and Questionnaires | 2002 |
In vitro anti-Helicobacter pylori activity of BAS-118, a new benzamide derivative.
Topics: Anti-Bacterial Agents; Benzamides; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer | 2002 |